H. Joenje

H. Joenje, E. Schoof, J. Beck, 2000, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells

Q. Waisfisz, G. Schuurhuis, G. Ossenkoppele, 2000, British journal of haematology.

Subtyping Analysis of Fanconi Anemia by Immunoblotting and Retroviral Gene Transfer

E. Guinan, A. D’Andrea, R. Mulligan, 1998, Molecular medicine.

Erythrocyte superoxide dismutase deficiency in Fanconi's anaemia established by two independent methods of assay.

R. Frants, H. Joenje, F. Arwert, 1979, Scandinavian journal of clinical and laboratory investigation.

Sequence variations in the Fanconi anaemia gene, FAC: pathogenicity of 1806insA and R548X and recognition of D195V as a polymorphic variant

H. Joenje, F. Arwert, M. Digweed, 1996, Human Genetics.

Fanconi anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines.

T. K. van den Berg, F. Kruyt, H. Joenje, 1996, Blood.

Novel frameshift mutation (1806insA) in exon 14 of the Fanconi anemia c gene, FAC

H. Joenje, F. Arwert, M. Rooimans, 1996, Human mutation.

Fanconi anaemia in Italy: High prevalence of complementation group A in two geographic clusters

A. Savoia, H. Joenje, D. Principe, 1996 .

Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype.

G. Pals, J. Soulier, J. Surrallés, 2007, American journal of human genetics.

Variable pathogenicity of exon 43del (FAA) in four Fanconi anaemia patients within a consanguineous family

H. Joenje, M. Alikaşifoğlu, J. Pronk, 1999, British journal of haematology.

Seckel syndrome exhibits cellular features demonstrating defects in the ATR-signalling pathway.

Gemma K. Alderton, P. Jeggo, A. Børglum, 2004, Human molecular genetics.

Heterogeneous spectrum of mutations in the Fanconi anaemia group A gene

G. Pals, R. Gibson, J. Cavenagh, 1999, European Journal of Human Genetics.

Loss of expression of FANCD2 protein in sporadic and hereditary breast cancer

P. V. van Diest, H. Joenje, J. D. de Winter, 2007, Breast Cancer Research and Treatment.

Yeast two-hybrid screens imply involvement of Fanconi anemia proteins in transcription regulation, cell signaling, oxidative metabolism, and cellular transport.

C. Mathew, Q. Waisfisz, H. Hoehn, 2003, Experimental cell research.

UvA-DARE (Digital Academic Repository) A protein prioritization approach tailored for the FA/BRCA pathway

P. May, J. Heringa, N. Ameziane, 2013 .

A cross‐linker‐sensitive myeloid leukemia cell line from a 2‐year‐old boy with severe Fanconi anemia and biallelic FANCD1/BRCA2 mutations

G. M. Taylor, J. Clayton-Smith, Q. Waisfisz, 2005, Genes, chromosomes & cancer.

Isolation of a cDNA representing the Fanconi anemia complementation group E gene.

N. Alon, C. Mathew, Q. Waisfisz, 2000, American journal of human genetics.

Evidence for complete epistasis of null mutations in murine Fanconi anemia genes Fanca and Fancg.

H. Joenje, F. Arwert, N. C. Cheng, 2011, DNA repair.

Respiratory failure and stimulation of glycolysis in Chinese hamster ovary cells exposed to normobaric hyperoxia.

H. Joenje, C. Jakobs, W. Schoonen, 1990, The Journal of biological chemistry.

Characterization of oxygen-resistant Chinese hamster ovary cells. III. Relative resistance of succinate and alpha-ketoglutarate dehydrogenases to hyperoxic inactivation.

H. Joenje, C. Jakobs, W. Schoonen, 1991, Free radical biology & medicine.

Effect of iron chelators on the cytotoxic and genotoxic action of hyperoxia in Chinese hamster ovary cells.

H. Joenje, C. V. van Berkel, J. Gille, 1992, Mutation research.

Oxygen-dependence of chromosomal aberrations in Fanconi's anaemia

H. Joenje, F. Arwert, A. Eriksson, 1981, Nature.

Interaction of singlet oxygen with DNA and biological consequences.

J. Aubry, H. Joenje, J. Lutgerink, 1992, Mutation research.

DNA damage by chemically generated singlet oxygen.

J. Aubry, H. Joenje, F. Arwert, 1987, Free radical research communications.

Inability of chemically generated singlet oxygen to break the DNA backbone.

J. Aubry, H. Joenje, F. Arwert, 1985, Free radical research communications.

Effects of lethal exposure to hyperoxia and to hydrogen peroxide on NAD(H) and ATP pools in Chinese hamster ovary cells.

E. Mullaart, J. Vijg, H. Joenje, 1989, Mutation research.

Effect of endogenous glutathione, superoxide dismutases, catalase, and glutathione peroxidase on adriamycin tolerance of Chinese hamster ovary cells.

H. Joenje, H. Pinedo, H. Keizer, 1988, Cancer research.

A common Fanconi anemia mutation in black populations of sub-Saharan Africa.

C. Lewis, C. Mathew, T. de Ravel, 2005, Blood.

A common founder mutation in FANCA underlies the world highest prevalence of Fanconi anemia in Gypsy families from Spain

C. Mathew, R. Marcos, A. Creus, 2004 .

Fanconi anaemia complementation groups in Germany and The Netherlands

H. Joenje, European Fanconi Anaemia Research group, 1996, Human Genetics.

Molecular and genealogical evidence for a founder effect in Fanconi anemia families of the Afrikaner population of South Africa

C. Mathew, T. de Ravel, R. Gibson, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Connecting Fanconi anemia to BRCA1

H. Joenje, F. Arwert, 2001, Nature Medicine.

Towards elucidating the role of ESCO1 in sister chromatid cohesion

R. Wolthuis, J. Dorsman, H. Joenje, 2010 .

Characterization, expression and complex formation of the murine Fanconi anaemia gene product Fancg

H. Joenje, F. Arwert, N. C. Cheng, 2002, Genes to cells : devoted to molecular & cellular mechanisms.

Should chromosome breakage studies be performed in patients with VACTERL association?

C. Mathew, G. Pals, D. Stoppa-Lyonnet, 2005, American journal of medical genetics. Part A.

Characterization of oxygen-tolerant Chinese hamster ovary cells. II. Energy metabolism and antioxidant status.

H. Joenje, P. Van Der Valk, A. Verkerk, 1988, Free radical biology & medicine.

Antioxidant status of Fanconi anemia fibroblasts

H. Wortelboer, H. Joenje, J. Gille, 1987, Human Genetics.

Effect of N-acetylcysteine on the antiproliferative action of X-rays or bleomycin in cultured human lung tumor cells

L. Blank, J. Haveman, J. V. Rijn, 2004, Journal of Cancer Research and Clinical Oncology.

Increased cytosolic pH in multidrug-resistant human lung tumor cells: effect of verapamil.

H. Joenje, H. Keizer, 1989, Journal of the National Cancer Institute.

Centromeric breakage as a major cause of cytogenetic abnormalities in oral squamous cell carcinoma

M. Welters, H. Joenje, M. Hermsen, 1996, Genes, chromosomes & cancer.

Fanconi anaemia in Italy: High prevalence of complementation group A in two geographic clusters

A. Savoia, H. Joenje, D. Principe, 1996, Human Genetics.

The formation of one-G deletions as a consequence of single-oxygen-induced DNA damage.

H. Joenje, J. Lutgerink, J. Retèl, 1994, Mutation research.

Identification, developmental expression and regulation of the Xenopus ortholog of human FANCG/XRCC9

H. Joenje, M. van Kogelenberg, J. Christian, 2007, Genes to cells : devoted to molecular & cellular mechanisms.

Cytogenetic alterations associated with P-glycoprotein- and non-P-glycoprotein-mediated multidrug resistance in SW-1573 human lung tumor cell lines.

F. Baas, J. Wiegant, H. Joenje, 1992, Cancer research.

Spontaneous functional correction of homozygous Fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism

C. Mathew, Q. Waisfisz, R. Gibson, 1999, Nature Genetics.

Mutagenicity of metabolic oxygen radicals in mammalian cell cultures.

H. Joenje, C. V. van Berkel, J. Gille, 1994, Carcinogenesis.

Oxygen: our major carcinogen?

H. Joenje, 1983, Medical hypotheses.

Cytogenetic toxicity of D2O in human lymphocyte cultures. Increased sensitivity in Fanconil's anemia

H. Joenje, A. H. Wanamarta, A. Oostra, 1983, Experientia.

Effect of oxygen tension on chromosomal aberrations in Fanconi anaemia

H. Joenje, B. Oostra, B. Oostra, 2004, Human Genetics.

Fragile sites and chromosome instability: the distribution of breaks induced by cis-diamine-clichloro-platinum (II) in Fanconi anemia lymphocyte cultures

B. Dallapiccola, B. Porfirio, D. Smeets, 2004, Human Genetics.

Unusual response to bifunctional alkylating agents in a case of Fanconi anaemia

H. Joenje, A. Eriksson, J. Kamp, 2004, Human Genetics.

Spontaneous Function Correction of Pathogenic Alleles in Inherited Diseases Resulting in Somatic Mosaicism

Q. Waisfisz, H. Joenje, 2006 .

Somatic Mosaicism in Fanconi Anemia: Molecular Basis and Clinical Significance

C. Mathew, A. Veerman, R. Gibson, 1997, European journal of human genetics : EJHG.

Mechanism of hyperoxia‐induced chromosomal breakage in chinese hamster cells

H. Joenje, C. V. van Berkel, J. Gille, 1993, Environmental and molecular mutagenesis.

Chromosomal instability in an oxygen-tolerant variant of Chinese hamster ovary cells.

E. Mullaart, J. Vijg, H. Joenje, 1989, Mutation research.

Cloning and characterization of murine Fanconi anemia group A gene: Fanca protein is expressed in lymphoid tissues, testis, and ovary

H. Joenje, F. Arwert, N. C. Cheng, 2000, Mammalian Genome.

High frequency of large intragenic deletions in the Fanconi anemia group A gene.

C. Mathew, H. Joenje, N. Morgan, 1999, American journal of human genetics.

Some characteristics of hyperoxia-adapted HeLa cells. A tissue culture model for cellular oxygen tolerance.

H. Joenje, P. Van Der Valk, J. Gille, 1985, Laboratory investigation; a journal of technical methods and pathology.

Inactivation of Mitochondrial Metabolism by Hyperoxia‐Induced Oxidative Stress a

H. Joenje, W. Schoonen, F. B. Pruijn, 1992, Annals of the New York Academy of Sciences.

Spectrum of mutations in the Fanconi anaemia group G gene, FANCG/XRCC9

C. Mathew, M. Thiel, H. Kayserili, 2000, European Journal of Human Genetics.

FANCD2 protein is expressed in proliferating cells of human tissues that are cancer‐prone in Fanconi anaemia

P. V. van Diest, H. Joenje, J. D. de Winter, 2003, The Journal of pathology.

Spectrum and significance of variants and mutations in the Fanconi anaemia group G gene in children with sporadic acute myeloid leukaemia

J. Birch, S. Meyer, H. Joenje, 2006, British journal of haematology.

Correction of cross-linker sensitivity of Fanconi anemia group F cells by CD33-mediated protein transfer.

H. Joenje, H. Youssoufian, K. Harutyunyan, 2001, Blood.

Spectrum of FANCA mutations in Italian Fanconi anemia patients: Identification of six novel alleles and phenotypic characterization of the S858R variant

A. Savoia, F. Della Ragione, R. Calzone, 2003, Human mutation.

Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line.

D. Housman, F. Baas, R. Arceci, 1990, Cancer research.

Correlation of multidrug resistance with decreased drug accumulation, altered subcellular drug distribution, and increased P-glycoprotein expression in cultured SW-1573 human lung tumor cells.

J. Lankelma, G. Schuurhuis, H. Joenje, 1989, Cancer Research.

Apparent absence of BRCA2 protein in a proportion of acute myeloid leukemia cell lines

G. Pals, Q. Waisfisz, A. Medhurst, 2004, Leukemia.

Lack of Sensitivity of Primary Fanconi's Anemia Fibroblasts to UV and Ionizing Radiation

H. Hoehn, D. Schindler, H. Joenje, 2004, Radiation research.

Bi‐allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia

C. Mathew, Q. Waisfisz, A. D’Andrea, 2003, British journal of haematology.

Functional correction of Fanconi anemia group A hematopoietic cells by retroviral gene transfer.

H. Joenje, J. Liu, C. Walsh, 1997, Blood.

Fanconi anaemia research: current status and prospects.

C. Mathew, H. Joenje, E. Gluckman, 1995, European journal of cancer.

Differential sensitivity of Fanconi anaemia lymphocytes to the clastogenic action of cis-diamminedichloroplatinum (II) and trans-diamminedichloroplatinum (II)

H. Joenje, F. Arwert, A. H. Wanamarta, 2004, Human Genetics.

Abstract of papers

E. Kroese, L. Bree, F. Zitman, 1987, Pharmaceutisch Weekblad.

Cytogenetic toxicity of antitumor platinum compounds in Fanconi's anemia

H. Joenje, F. Arwert, A. Eriksson, 1982, Human Genetics.

The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM

Hans Joenje, Johan P. de Winter, Christopher G. Mathew, 2000, Nature Genetics.

The Fanconi anaemia group G gene FANCG is identical with XRCC9

Hans Joenje, Johan P. de Winter, Quinten Waisfisz, 1998, Nature Genetics.

The fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation.

A. D’Andrea, S. Asano, G. Kupfer, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA

Hans Joenje, David F. Callen, Anna Savoia, 1996, Nature Genetics.

prevalence of Fanconi anemia in Gypsy families from Spain A common founder mutation in FANCA underlies the world's highest

C. Mathew, R. Marcos, A. Creus, 2013 .

Lack of cross-resistance to X-irradiation in oxygen-resistant mammalian cell lines.

H. Joenje, J. van den Berg, J. V. van Rijn, 1985, Journal of free radicals in biology & medicine.

An atypical case of Fanconi anemia in elderly sibs.

H. Joenje, F. Arwert, A. V. van Essen, 1997, American journal of medical genetics.

ERYTHROCYTE SUPEROXIDE-DISMUTASE DEFICIENCY IN FANCONI'S ANÆMIA

R. Frants, H. Joenje, F. Arwert, 1978, The Lancet.

Fanconi anemia complementation group E: clinical and cytogenetic data of the first patient

R. Wegner, H. Joenje, T. Schroeder-Kurth, 1996, Clinical genetics.

Fancm-deficient mice reveal unique features of Fanconi anemia complementation group M.

H. Joenje, J. D. de Winter, M. A. van der Valk, 2009, Human molecular genetics.

Impaired FANCD2 monoubiquitination and hypersensitivity to camptothecin uniquely characterize Fanconi anemia complementation group M.

David A. Williams, P. Andreassen, E. Grassman, 2009, Blood.

Fanconi anemia and DNA replication repair.

Hans Joenje, Ketan J Patel, K. J. Patel, 2007, DNA repair.

The emerging genetic and molecular basis of Fanconi anaemia

Hans Joenje, K. J. Patel, H. Joenje, 2001, Nature Reviews Genetics.

Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity.

G. Schuurhuis, H. Joenje, H. Pinedo, 1990, Pharmacology & therapeutics.

The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J

C. Mathew, G. Pals, Q. Waisfisz, 2005, Nature Genetics.

Fanconi anemia is associated with a defect in the BRCA2 partner PALB2

Hans Joenje, Bing Xia, Weidong Wang, 2007, Nature Genetics.

Diagnosis of Fanconi Anemia: Mutation Analysis by Multiplex Ligation-Dependent Probe Amplification and PCR-Based Sanger Sequencing

N. Ameziane, H. Joenje, J. D. de Winter, 2012, Anemia.

A novel ubiquitin ligase is deficient in Fanconi anemia

C. Bishop, Q. Waisfisz, Weidong Wang, 2003, Nature Genetics.

FANCE: the link between Fanconi anaemia complex assembly and activity

Hans Joenje, F. Gergely, K. J. Patel, 2002, The EMBO journal.

Defects in the Fanconi Anemia Pathway and Chromatid Cohesion in Head and Neck Cancer.

S. Feller, B. Ylstra, N. Ameziane, 2015, Cancer research.

Warsaw breakage syndrome, a cohesinopathy associated with mutations in the XPD helicase family member DDX11/ChlR1.

Hans Joenje, K. Chrzanowska, H. Joenje, 2010, American journal of human genetics.

CHAPTER Chromatid cohesion defects in human cancer cell lines 6

B. Ylstra, N. Ameziane, H. Joenje, 2010 .

Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation.

P. V. van Diest, M. Hermsen, J. Walboomers, 1998, Journal of clinical pathology.

Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumors

C. Mathew, S. Mok, A. D’Andrea, 2003, Nature Medicine.

Diagnosis of Fanconi Anemia: Mutation Analysis by Next-Generation Sequencing

B. Ylstra, N. Ameziane, Y. Ariyurek, 2012, Anemia.

X-linked inheritance of Fanconi anemia complementation group B

G. Pals, Weidong Wang, A. Medhurst, 2004, Nature Genetics.

A novel Fanconi anaemia subtype associated with a dominant-negative mutation in RAD51

L. Hood, J. Roach, P. May, 2015, Nature Communications.

No Evidence for FANCF Gene Silencing in Head-and-Neck Squamous Cell Carcinomas

C. R. Leemans, N. Ameziane, H. Joenje, 2008, Cellular oncology : the official journal of the International Society for Cellular Oncology.

Clinical and molecular characteristics of squamous cell carcinomas from Fanconi anemia patients.

C. R. Leemans, J. Soulier, P. Snijders, 2008, Journal of the National Cancer Institute.

Fanconi anemia: adult head and neck cancer and hematopoietic mosaicism.

G. Pals, B. Alter, H. Joenje, 2005, Archives of otolaryngology--head & neck surgery.

Genetic subtyping of Fanconi anemia by comprehensive mutation screening

G. Pals, N. Ameziane, H. Joenje, 2008, Human mutation.

A Multiprotein Nuclear Complex Connects Fanconi Anemia and Bloom Syndrome

Weidong Wang, S. Sechi, H. Joenje, 2003, Molecular and Cellular Biology.

Spontaneous abrogation of the G₂DNA damage checkpoint has clinical benefits but promotes leukemogenesis in Fanconi anemia patients.

J. Soulier, Q. Waisfisz, D. Stoppa-Lyonnet, 2011, The Journal of clinical investigation.

Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2.

Q. Waisfisz, A. D’Andrea, M. Sasaki, 2003, Cancer research.

The Fanconi Anemia Gene Product FANCF Is a Flexible Adaptor Protein*

Q. Waisfisz, K. J. Patel, A. Medhurst, 2004, Journal of Biological Chemistry.

The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG.

Q. Waisfisz, F. Kruyt, H. Joenje, 2000, Human molecular genetics.

Localisation of a Fanconi anaemia gene to chromosome 9p

T. Wienker, H. Hoehn, R. Wegner, 1998, European Journal of Human Genetics.

Linkage analysis of Fanconi anaemia in Italy and mapping of the complementation group A gene

B. Dallapiccola, A. Savoia, H. Joenje, 1996, Human Genetics.

Clinical variability of Fanconi anemia (type C) results from expression of an amino terminal truncated Fanconi anemia complementation group C polypeptide with partial activity.

A. D’Andrea, M. Grompe, G. Kupfer, 1996, Blood.

Immortalization of four new fanconi anemia fibroblast cell lines by an improved procedure

R. Moses, H. Joenje, S. Olson, 1996, Somatic cell and molecular genetics.

Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes.

C. Mathew, Q. Waisfisz, H. Joenje, 2004, Blood.

Complementation analysis in Fanconi anemia: assignment of the reference FA-H patient to group A.

C. Mathew, Q. Waisfisz, A. D’Andrea, 2000, American journal of human genetics.

The Fanconi anemia group E gene, FANCE, maps to chromosome 6p.

C. Mathew, Q. Waisfisz, R. Wegner, 1999, American journal of human genetics.

Localisation of the Fanconi anaemia complementation group A gene to chromosome 16q24.3

C. Mathew, D. Easton, R. Gibson, 1995, Nature Genetics.

Comparative genomic hybridization: a new tool in cancer pathology.

G. Meijer, J. Baak, H. Joenje, 1996, Human pathology.

2 Loss of Rb Proteins Causes Genomic Instabilty in the Abence of Mitogenic Signaling

R. Banerjee, M. V. Vugt, F. Foijer, 2013 .

Loss of Rb proteins causes genomic instability in the absence of mitogenic signaling.

R. Banerjee, M. V. van Vugt, F. Foijer, 2010, Genes & development.

mitogenic signaling Loss of Rb proteins causes genomic instability in the absence of Material

R. Banerjee, M. V. Vugt, F. Foijer, 2010 .

Erratum: Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA

N. Alon, G. Pals, M. Buchwald, 1996, Nature Genetics.

Oxygen Metabolism and Chromosomal Breakage in Fanconi Anemia

H. Joenje, J. Gille, 1989 .

Identification of the Fanconi Anemia Complementation Group I Gene, FANCI

C. Mathew, G. Pals, Q. Waisfisz, 2007, Cellular oncology : the official journal of the International Society for Cellular Oncology.

A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M

C. Mathew, Weidong Wang, A. Medhurst, 2005, Nature Genetics.

Coregulation of FANCA and BRCA1 in human cells

H. Meijers-Heijboer, J. Dorsman, H. Joenje, 2014, SpringerPlus.

Fanconi Anemia Proteins Are Required To Prevent Accumulation of Replication-Associated DNA Double-Strand Breaks

Weidong Wang, J. Gautier, K. Cimprich, 2006, Molecular and Cellular Biology.

The Cellular Phenotype of Roberts Syndrome Fibroblasts as Revealed by Ectopic Expression of ESCO2

R. Wolthuis, Wouter van Zon, Q. Waisfisz, 2009, PloS one.

Roberts syndrome is caused by mutations in ESCO2, a human homolog of yeast ECO1 that is essential for the establishment of sister chromatid cohesion

E. Jabs, Q. Waisfisz, H. Kayserili, 2005, Nature Genetics.

Genes amplified and overexpressed in human multidrug-resistant cell lines.

F. Baas, R. Ozols, A. M. van der Bliek, 1988, Cancer research.

Publisher Correction: BIRC2–BIRC3 amplification: a potentially druggable feature of a subset of head and neck cancers in patients with Fanconi anemia

R. Wolthuis, N. Ameziane, J. Dorsman, 2022, Scientific Reports.

BIRC2–BIRC3 amplification: a potentially druggable feature of a subset of head and neck cancers in patients with Fanconi anemia

R. Wolthuis, N. Ameziane, J. Dorsman, 2022, Scientific reports.

Multiple TPR motifs characterize the Fanconi anemia FANCG protein.

H. Joenje, J. D. de Winter, F. Arwert, 2004, DNA repair.

Analysis of baseline and cisplatin-inducible gene expression in Fanconi anemia cells using oligonucleotide-based microarrays

Q. Waisfisz, Johnson M Liu, H. Joenje, 2002, BMC blood disorders.

Drug sensitivity spectra in Fanconi anemia lymphoblastoid cell lines of defined complementation groups.

N. Alon, M. Buchwald, H. Joenje, 1999, Mutation research.

Confounding factors in the diagnosis of Fanconi anaemia.

H. Hoehn, H. Joenje, F. Arwert, 1998, American journal of medical genetics.

Mutations of the Fanconi anemia group A gene (FAA) in Italian patients.

A. Savoia, P. Strippoli, H. Joenje, 1997, American journal of human genetics.

FAAP100 is essential for activation of the Fanconi anemia‐associated DNA damage response pathway

Weidong Wang, D. Schindler, A. Medhurst, 2007, The EMBO journal.

Diagnostic Overlap between Fanconi Anemia and the Cohesinopathies: Roberts Syndrome and Warsaw Breakage Syndrome

H. Joenje, J. D. de Winter, M. Rooimans, 2010, Anemia.

Hypermethylation of the FANCC and FANCL Promoter Regions in Sporadic Acute Leukaemia

Q. Waisfisz, D. Reinhardt, C. Zwaan, 2008, Cellular oncology : the official journal of the International Society for Cellular Oncology.

A "late-but-fitter revertant cell" explains the high frequency of revertant mosaicism in epidermolysis bullosa

R. Hofstra, G. T. te Meerman, H. Joenje, 2012, PloS one.

CHAPTER 6 Deficiency of the centrosomal protein CEP 170 is associated with microcephaly

E. Bakker, J. Dorsman, S. Piersma, 2015 .

sub-Saharan Africa A common Fanconi anemia mutation in black populations of

C. Lewis, C. Mathew, I. Demuth, 2013 .

Evolutionary Clues to the Molecular Function of Fanconi Anemia Genes

H. Joenje, J. D. de Winter, F. Arwert, 2002, Acta Haematologica.

Cancer Cell Line Selection for Doxorubicin Resistance in a Human Lung Vitro in Resistance Precedes P-Glycoprotein Expression during Non-P-Glycoprotein mediated Mechanism for Multidrug

D. Housman, F. Baas, R. Arceci, 2006 .

Different nuclease activities in competent and noncompetent Bacillus subtilis

G. Venemâ, H. Joenje, 1975, Journal of bacteriology.

Genetic toxicology of oxygen.

H. Joenje, Hans Joenje, 1989, Mutation research.

Interactions Between Exogenous Deoxyribonucleic Acid and Membrane Vesicles Isolated from Bacillus subtilis 168

G. Venemâ, H. Joenje, W. N. Konings, 1974, Journal of bacteriology.

Interactions between exogenous deoxyribonucleic acid and membrane vesicles isolated from competent and noncompetent Bacillus subtilis

G. Venemâ, H. Joenje, W. N. Konings, 1975, Journal of bacteriology.

DNA binding and deoxyribonuclease activity in Bacillus subtilis during temperature-induced competence development.

G. Venemâ, H. Joenje, M. Espinosa, 1980, Journal of general microbiology.

Stimulation of the development of competence by culture fluids in Bacillus subtilis transformation.

G. Venemâ, H. Joenje, M. Gruber, 1972, Biochimica et biophysica acta.

Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM.

S. West, Weidong Wang, Alberto Ciccia, 2007, Molecular cell.

Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2.

Q. Waisfisz, A. Medhurst, H. Joenje, 2006, Mutation research.

Chromosomal instability and progressive loss of chromosomes in HeLa cells during adaptation to hyperoxic growth conditions.

H. Joenje, J. Gille, 1989, Mutation research.

Characterization of an oxygen-tolerant cell line derived from Chinese hamster ovary

E. Roubos, H. Joenje, J. Gille, 2004, Cell and Tissue Research.

Correspondence re: M. S. van der Heijden et al., Fanconi Anemia Gene Mutations in Young-onset Pancreatic Cancer. Cancer Res., 63: 2585-2588, 2003 [2] (multiple letters)

R. Hruban, S. Kern, G. Pals, 2003 .

Hepatoma cells adapted to proliferate under normally lethal hyperthermic stress conditions show rapid decay of thermoresistance and heat shock protein synthesis when returned to 37 degrees C.

R. van Wijk, H. Joenje, J. Souren, 1995, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Assessment of chromosomal gains and losses in oral squamous cell carcinoma by comparative genomic hybridisation.

J. Baak, H. Joenje, M. Hermsen, 1997, Oral oncology.

Effect of artificial electron acceptors on the cytotoxicity of mitomycin C and doxorubicin in human lung tumor cells.

H. Joenje, H. Pinedo, H. Keizer, 1989, European journal of cancer & clinical oncology.

Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2.

Susan M. Gordon, C. Mathew, P. Sung, 2006, DNA repair.

The ambivalent role of glutathione in the protection of DNA against singlet oxygen.

H. Joenje, J. Retèl, M. Lafleur, 1994, Free radical research.

Biological consequences of DNA damage introduced in bacteriophage PM2 DNA by hydrogen peroxide-mediated free radical reactions.

H. Joenje, J. Gille, J. Retèl, 1996, Carcinogenesis.

Association between bleomycin genotoxicity and non-constitutional risk factors for head and neck cancer.

G. Snow, N. de Vries, H. Joenje, 1993, Cancer letters.

Specific activity of human erythrocyte superoxide dismutase as a function of donor age. A brief note

R. Frants, H. Joenje, F. Arwert, 1978, Mechanisms of Ageing and Development.

Correlation of multidrug distribution, and increased P-glycoprotein expression in cultured SW-1573 human lung tumor cells

J. Lankelma, G. Schuurhuis, H. Joenje, 1989 .

A histone-fold complex and FANCM form a conserved DNA-remodeling complex to maintain genome stability.

Weidong Wang, Ting-Yi Lin, A. Stasiak, 2010, Molecular cell.

A ubiquitin-binding protein, FAAP20, links RNF8-mediated ubiquitination to the Fanconi anemia DNA repair network.

Weidong Wang, D. Schindler, H. Joenje, 2012, Molecular cell.

Expression of the Fanconi anemia gene FAC in human cell lines: lack of effect of oxygen tension.

M. Buchwald, F. Kruyt, R. Wevrick, 1995, Blood cells, molecules & diseases.

Lack of large genomic deletions in BRIP1, PALB2, and FANCD2 genes in BRCA1/2 negative familial breast cancer

Q. Waisfisz, H. Meijers-Heijboer, M. Adank, 2009, Breast Cancer Research and Treatment.

Effect of antioxidants on hyperoxia-induced chromosomal breakage in Chinese hamster ovary cells: protection by carnosine

H. Joenje, J. Gille, P. Pasman, 1991 .

Update of the human and mouse Fanconi anemia genes

E. Bruford, D. Thompson, V. Vasiliou, 2015, Human Genomics.

SOD-A and chromosome 21

H. Joenje, R. Slater, N. Leschot, 1981, Human Genetics.

Conflicting Findings in a Familial Translocation (9p24;21q214)

H. Joenje, R. Slater, N. Leschot, 1981 .

Fanconi anemia A due to a novel frameshift mutation in hotspot motifs: Lack of FANCA protein

H. Kayserili, H. Joenje, J. D. de Winter, 2000, Human Mutation.

Cytogenetic toxicity of paraquat and streptonigrin in Fanconi's anemia.

H. D. de Koning, H. Joenje, F. Arwert, 1987, Cancer genetics and cytogenetics.

Clastogenicity of cyclophosphamide in Fanconi's anemia lymphocytes without exogenous metabolic activation.

H. Joenje, A. Oostra, 1986, Cancer genetics and cytogenetics.

Isolation and partial characterization of a temperature-sensitive mutant of Bacillus subtilis impaired in the development of competence for genetic transformation.

W. Admiraal, G. Venemâ, H. Joenje, 1973, Journal of general microbiology.

Effect of normobaric hyperoxia on antioxidant defenses of HeLa and CHO cells.

H. Wortelboer, H. Joenje, J. Gille, 1988, Free radical biology & medicine.

Involvement of the Fanconi's anemia protein FAC in a pathway that signals to the cyclin B/cdc2 kinase.

F. Kruyt, H. Joenje, L. M. Dijkmans, 1997, Cancer research.

A reason for intermittent fasting to suppress the awakening of dormant breast tumors

Hans V. Westerhoff, Jan Lankelma, Bob Kooi, 2015, Biosyst..

Exon 6 skipping in the fanconi anemia C gene associated with a nonsense/missense mutation (775C→T) in exon 5: The first example of a nonsense mutation in one exon causing skipping of another downstream

C. Mathew, G. Pals, R. Gibson, 1998, Human mutation.

bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 23, 2013. For personal use

C. Mathew, R. Marcos, A. Creus, 2022 .

Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes.

C. Mathew, Q. Waisfisz, H. Joenje, 2004, Blood.

Prevalence of Fanconi Anemia in Gypsy Families from Spain Underlies the World Highest Fanca a Common Founder Mutation In

A. Creus, J. Surrallés, B. Hoffman, 2022 .

Heterozygote FANCD2 mutations associated with childhood T Cell ALL and testicular seminoma

E. Klopocki, A. Whetton, J. Dorsman, 2012, Familial Cancer.

The Fanconi anemia pathway requires FAA phosphorylation and FAAyFAC nuclear accumulation (mitomycin Cyleukemiaycancer susceptibility)

S. Asano, G. Kupfer, H. Joenje, 1998 .

Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes.

C. Mathew, Q. Waisfisz, H. Joenje, 2004, Blood.

Metabolism: Alcohol, DNA and disease

H. Joenje, 2011, Nature.

A Protein Prioritization Approach Tailored for the FA/BRCA Pathway

P. May, J. Heringa, N. Ameziane, 2013, PloS one.

The Fanconi Anemia Gene Product FANCF Is a Flexible Adaptor Protein*

Q. Waisfisz, K. J. Patel, A. Medhurst, 2004, Journal of Biological Chemistry.

A common founder mutation in FANCA underlies the world's highest prevalence of Fanconi anemia in Gypsy families from Spain.

C. Mathew, R. Marcos, A. Creus, 2005, Blood.

Letter to the editor for “Update of the human and mouse Fanconi anemia genes”

E. Bruford, D. Thompson, V. Vasiliou, 2016, Human Genomics.

Heterozygote FANCD2 mutations associated with childhood T Cell ALL and testicular seminoma

E. Klopocki, A. Whetton, J. Dorsman, 2012, Familial Cancer.